Patents Assigned to Pharmasolutions, Inc.
  • Publication number: 20230310321
    Abstract: Provided herein is a coated particle comprising: (i) a microparticle that comprises a pharmaceutically acceptable excipient and (ii) nanoparticles of a therapeutic agent, wherein the surface of the microparticle is coated with the nanoparticles. Also provided herein is a pharmaceutical composition comprising the coated particle. Furthermore, provided herein are methods of their preparation.
    Type: Application
    Filed: May 24, 2023
    Publication date: October 5, 2023
    Applicant: Nano PharmaSolutions, Inc.
    Inventors: Kay Olmstead, Saeyeon Lee, Seok-Keun Koh
  • Publication number: 20210290543
    Abstract: Provided herein is a coated particle comprising: (i) a microparticle that comprises a pharmaceutically acceptable excipient and (ii) nanoparticles of a therapeutic agent, wherein the surface of the microparticle is coated with the nanoparticles. Also provided herein is a pharmaceutical composition comprising the coated particle. Furthermore, provided herein are methods of their preparation.
    Type: Application
    Filed: February 18, 2021
    Publication date: September 23, 2021
    Applicant: Nano PharmaSolutions, Inc.
    Inventors: Kay Olmstead, Saeyeon Lee, Seok-Keun Koh
  • Patent number: 6638522
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of Cyclosporin, in association with a pharmaceutical carrier, said carrier comprising a cyclosporin solubilizing effective amount of a propylene glycol monoester of C6-C18 fatty acid having at least 60% by weight monoester based on the total weight of the propylene glycol ester and a non-ionic surfactant.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: October 28, 2003
    Assignee: Pharmasolutions, Inc.
    Inventor: Nirmal Mulye
  • Patent number: 6436430
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of a lipophilic drug, in association with a pharmaceutical carrier, said carrier comprising a lipophilic drug solubilizing effective amount of a propylene glycol monoester of C6-C18 fatty acid having at least 60% by weight monoester based on the total weight of the propylene glycol ester and a non-ionic surfactant.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: August 20, 2002
    Assignee: Pharmasolutions, Inc.
    Inventor: Nirmal Mulye
  • Patent number: 6057289
    Abstract: The present invent is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of cyclosporin in association with a pharmaceutical carrier, said carrier comprising a drug solubilizing effective amount of a fatty acid having 6-22 carbon atoms and a non-ionic surfactant.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: May 2, 2000
    Assignee: Pharmasolutions, Inc.
    Inventor: Nirmal Mulye